← 返回事件
持续讨论商业

Eli Lilly is partnering with China's InnoCare on a drug deal worth up to $3.35 billion

发生了什么

Lilly will pay $100 million upfront to work with the Beijing-based biotech on as many as five undisclosed drug targets

摘要按规则整理自下方来源原文

来源